SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
128.80    4.60 (3.70%)
Bid:
128.20
Ask:
129.60
Spread: 1.40 (1.092%)
Market Cap: £536.34m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

AGM Statement

7 Dec 2018 07:00

RNS Number : 4270J
James Halstead PLC
07 December 2018
 

7 December 2018

 

JAMES HALSTEAD PLC

 

Chairman's Statement to the Annual General Meeting

 

 

James Halstead plc, the commercial flooring company, is holding its 103rd AGM today at 12.00 noon at which the Chairman, Mr Anthony Wild, will make the following statement: 

"As is customary, I would like to give you an update on trading now that we are five months into the current financial year.

 

In this, my first year as Chairman, I am pleased to announce we have continued our long record of increased dividend payments with the proposed final dividend of 9.65p, being paid today, and we continue to grow our cash balances.

There is much speculation on the future trading relationship of the UK with Europe but our trading is global and we, as a Board, are confident of growth but mindful of potential short term issues. Our robust balance sheet and strong cash flows are undoubtedly key strengths.

It was noted in our Annual Results, announced on 25 September 2018, that we had several new ranges launched into the market place in recent months.

Following a £2m investment in Palettone, our design led homogenous vinyl sheet collection, I am pleased to report that customer interest has already exceeded our expectations and examples of installations are the Charité Universitätsmedizin, Berlin and the Théâtre du Petit Saint Martin on Rue René Boulanger, Paris. In addition Polysafe Verona Pure Colour (our dementia friendly flooring) has been installed in Marymount Nursing home in Dublin.

In conclusion, trading to date has been encouraging and we have traded ahead of last year in terms of turnover and profits for the first five months. I am confident in the prospects of the Company and more importantly I remain confident of maintaining our impressive record of dividend growth."

 

- Ends -

 

 

Enquiries:

 

James Halstead:

Telephone: 0161 767 2500

Mark Halstead, Chief Executive

 

Gordon Oliver, Finance Director

 

 

 

Hudson Sandler:

Telephone: 020 7796 4133

Nick Lyon / Nick Moore

 

 

 

Panmure Gordon (Nomad and Joint Brokers):

Telephone: 020 7886 2500

Ben Thorne / Dominic Morley

 

 

 

Arden (Joint Broker):

Telephone: 020 7614 5900

Andrew Simms

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMUSAVRWBAURAA
Date   Source Headline
16th Mar 20153:46 pmRNSNotice of Interim Results
3rd Mar 20153:00 pmRNSTotal Voting Rights
30th Jan 20157:00 amRNSPre Close Trading Statement
6th Jan 20154:11 pmRNSBlocklisting Interim Review
6th Jan 201511:21 amRNSTotal Voting Rights
5th Dec 20147:00 amRNSAGM Statement
3rd Nov 20147:00 amRNSTotal Voting Rights
24th Oct 20143:24 pmRNSAnnual Financial Report
1st Oct 20149:25 amRNSTotal Voting Rights
1st Oct 20147:00 amRNSPreliminary Results
27th Aug 20147:00 amRNSNotice of Preliminary Results
31st Jul 20147:00 amRNSPre-Close Trading Statement
21st Jul 20143:50 pmRNSDirectors' Shareholdings
17th Jul 20144:51 pmRNSDirectors exercise of share options
1st Jul 20147:00 amRNSBlocklisting Interim Review
1st Jul 20147:00 amRNSTotal Voting Rights
3rd Jun 20147:00 amRNSTotal Voting Rights
1st May 201411:10 amRNSTotal Voting Rights
31st Mar 20147:00 amRNSInterim Results
3rd Feb 20147:00 amRNSPre Close Trading Statement
20th Jan 20149:40 amRNSPurchase of own shares and directors' dealings
6th Jan 20144:30 pmRNSBlocklisting Interim Review
6th Dec 20137:00 amRNSAGM Statement
4th Nov 201311:00 amRNSTotal Voting Rights
28th Oct 20135:25 pmRNSAnnual Financial Report
28th Oct 20134:18 pmRNSDirectors exercise of share options
4th Oct 201312:40 pmRNSTotal Voting Rights
1st Oct 20137:00 amRNSPreliminary Announcement of Audited Results
23rd Sep 201312:55 pmRNSNotice of Preliminary Results
31st Jul 20137:00 amRNSPre-close Trading Statement
16th Jul 201312:00 pmRNSBlocklisting Interim Review
21st Jun 20134:35 pmRNSPrice Monitoring Extension
2nd May 201311:10 amRNSTotal Voting Rights
28th Mar 20137:00 amRNSInterim Results
1st Feb 201311:15 amRNSNotice of Interim Results Date Change
31st Jan 20134:00 pmRNSTotal Voting Rights
31st Jan 20137:00 amRNSPre-close Trading Statement
10th Jan 201311:00 amRNSIssue of Equity and Total Voting Rights
7th Jan 20139:00 amRNSBlocklisting Interim Review
11th Dec 20127:00 amRNSBonus Issue
7th Dec 20124:40 pmRNSSecond Price Monitoring Extn
7th Dec 20124:35 pmRNSPrice Monitoring Extension
7th Dec 20127:00 amRNSAGM Statement
3rd Dec 20127:00 amRNSTotal Voting Rights
1st Nov 20127:00 amRNSTotal Voting Rights
23rd Oct 20127:00 amRNSAnnual Financial Report
1st Oct 20127:00 amRNSPreliminary Audited Results
3rd Sep 20127:00 amRNSTotal Voting Rights
30th Jul 20127:00 amRNSPre-close Trading Statement
2nd Jul 20129:00 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.